Landscapes / Companies
AGO Research GmbH not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 3 in all
Trials
3 active
7 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Durvalumabnot checked |
Programmed death ligand-1 blocker |
Phase 2 | Jan 2028Phase 2 trial completes | ||
| How it works | Releases a brake on the immune system (PD-1 or PD-L1) so it attacks cancer cells | ||||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Epithelial Ovarian Cancer | ||||
| Open drug page | |||||
Olaparibnot checked |
Poly(ADP-Ribose) polymerase inhibitor |
Phase 2 | Jan 2028Phase 2 trial completes | ||
| How it works | Blocks PARP | ||||
| Next date | Jan 2028 · Phase 2 trial completes | ||||
| Also tested for | Epithelial Ovarian Cancer | ||||
| Open drug page | |||||
About
- No active trial
- PLD
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021